{"product_id":"university-of-miami-miami-valves-2025","title":"University of Miami Miami Valves 2025","description":"\u003cdiv\u003e\n\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"ma-product\"\u003e\u003csection\u003e\n\u003ch1 class=\"product_title entry-title\"\u003eUniversity of Miami Miami Valves 2025\u003c\/h1\u003e\n\u003cstrong\u003e+ Include: 51 Videos (.mp4) + 51 Audios (.mp3) + 51 Subtitles (.vtt) + 51 PDFs, size: 11.1 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: interventional cardiologists, cardiac surgeons\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003ch2 data-path-to-node=\"0\"\u003e1. Overview\u003c\/h2\u003e\n\u003cp data-path-to-node=\"1\"\u003eThe University of Miami Miami Valves 2025 is a premier structural heart disease conference focusing on the latest innovations in transcatheter valve therapies. The course provides a deep dive into TAVR, TMVR, and tricuspid interventions, alongside cutting-edge research on AI integration and novel device clinical trials.\u003c\/p\u003e\n\u003cp data-path-to-node=\"1\"\u003e\u003cb data-index-in-node=\"322\" data-path-to-node=\"1\"\u003eCourse Date:\u003c\/b\u003e 2025\u003c\/p\u003e\n\u003ch2 data-path-to-node=\"2\"\u003e2. Learning Objectives\u003c\/h2\u003e\n\u003cul data-path-to-node=\"3\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"3,0,0\"\u003eEvaluate recent clinical trial data for TAVR, including the PROPEL and EASY II trials.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"3,1,0\"\u003eDiscuss the management of complex aortic valve cases, such as bicuspid anatomy and chronic aortic regurgitation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"3,2,0\"\u003eAnalyze emerging technologies for mitral valve repair and replacement, focusing on TEER durability and neo-LVOT simulation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"3,3,0\"\u003eReview FDA-approved and investigational therapies for tricuspid regurgitation, including replacement and edge-to-edge repair.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"3,4,0\"\u003eImplement novel techniques for structural interventions, including PFO closure in older adults and management of paravalvular leaks.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-path-to-node=\"4\"\u003e3. Target Audience\u003c\/h2\u003e\n\u003cbr\u003eBest for interventional cardiologists and cardiac surgeons who want updates on structural heart disease and transcatheter valve therapies.\u003cbr\u003e\u003ch2 data-path-to-node=\"6\"\u003e4. Topics\u003c\/h2\u003e\n\u003col data-path-to-node=\"8\" start=\"1\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,0,0\"\u003eWhat Did We Learn from TAVR UNLOAD\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,1,0\"\u003eSelected Case of CE Approved TAVR Valve – Acurate Neo2\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,2,0\"\u003eHybrid TAVR\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,3,0\"\u003eSeptal Occulders- Not Just for the Intra-Atrial Septum\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,4,0\"\u003eNovel Vascular Closure Device (xDot) – First in Human Experience\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,5,0\"\u003eAI for Cardiovascular Staff Support\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,6,0\"\u003eNovel RV Restoration System\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,7,0\"\u003eNovel TMVR Devices\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,8,0\"\u003eLatest Clinical Update – Silara MiBridge. Direct Annuloplasty System\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,9,0\"\u003eNovel Transcatheter Mitral Annuloplasty Repair. Technology and Pre-Clinical Experience\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,10,0\"\u003eEASY II Trial – Pioneering Temporary A-V Sequential Pacing for Enhanced Cardiac Care\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,11,0\"\u003eNovel Device for Pulmonic Valve – Alterra\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,12,0\"\u003eTricuspid Valve Replacement in a Patient with a Torn Leaflet\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,13,0\"\u003eUnderstanding the Tricuspid Regurgitation (Pathologist Perspective)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,14,0\"\u003eMulti Modality Imaging of Tricuspid Valve\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,15,0\"\u003eSurgical Treatment of Tricuspid Valve\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,16,0\"\u003eFDA Approved Edge to Edge Repair of Tricuspid (What We Know)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,17,0\"\u003eFDA Approved Tricuspid Valve Replacement – What We Know\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,18,0\"\u003eTTVR with the Evoque Valve via the Transjugular Approach\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,19,0\"\u003eExpanding Indications for PFO Closure Patients ≥ 60-Years Old\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,20,0\"\u003eA Case of Severe Bioprosthetic Valve Dysfunction\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,21,0\"\u003eNeo-LVOT Simulations for TMVR\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,22,0\"\u003ePreventing LVOT Obstruction During TMVR – Septal Reduction and LAMPOON – What We Know\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,23,0\"\u003eTMVR and the Tendyne Roll-In and MAC Experience\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,24,0\"\u003eAPOLLO Trial MAC Cohort\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,25,0\"\u003eInvestigational Transeptal TMVR – SAPIEN M3\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,26,0\"\u003eViMAC with SUPERMAN\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,27,0\"\u003eImaging to Plan Mitral Valve Procedures\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,28,0\"\u003eDurability of Edge-to-Edge Repair\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,29,0\"\u003eTEER in Moderate MR\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,30,0\"\u003eRecurrent Heart Failure after M-TEER – More than the Mitral Valve\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,31,0\"\u003eClinical Trials for Mitral Regurgitation Beyond TEER – Where to Next\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,32,0\"\u003eProgress in Mitral Valve Replacement\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,33,0\"\u003eLAVA-ECMO for Cardiogenic Shock and Acute Aortic Regurgitation as a Bridge to Valve Replacement\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,34,0\"\u003ePathological Insights to the Native Aortic Valve Regurgitation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,35,0\"\u003eDedicated TAVR Devices for Chronic Aortic Regurgitation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,36,0\"\u003eSingle Center Results for a Balloon Expandable Valve in Native Valve AI\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,37,0\"\u003eWhere Are We with TAVR for Bicuspid\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,38,0\"\u003eAI Simulation Assisted TAVR\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,39,0\"\u003eA Case of Bicuspid TAVR with AI Planning\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,40,0\"\u003eTAVR 2025 – The Begins….\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,41,0\"\u003eTAVR US Origin\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,42,0\"\u003eClinical Trial Propel TAVR Forward – Building the Evidence Base for Low Surgical Risk Patients\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,43,0\"\u003eLate PVL After BE THV\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,44,0\"\u003eTranscatheter Management of Failed Ross Procedure\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,45,0\"\u003eShort Term ACS Post TAVR\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,46,0\"\u003eOn the Shoulders of Our Mentors… How to Maximize Your Career Development Pathway\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,47,0\"\u003eLeft Atrium to Coronary Sinus Shunting – Edwards’ APTURE Shunt and ALT-FLOW II Trial\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,48,0\"\u003eTranscatheter Treatment of a Sinus Venous ASD with Partial Anomalous Pulmonary Venous Return\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,49,0\"\u003ePercutaneous Tricuspid Valve Intervention(s)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,50,0\"\u003ePercutaneous Stenting of Severe LVAD Outflow Graft Obstruction\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954542284898,"sku":"MED-AMB05773","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/University-of-Miami-Miami-Valves-2025.jpg?v=1779379380","url":"https:\/\/meducourse.com\/products\/university-of-miami-miami-valves-2025","provider":"Meducourse","version":"1.0","type":"link"}